Susan works in the field of Pediatric Hematology & Oncology. She graduated from Icahn School of Medicine at Mount Sinai. Icahn School of Medicine at Mount Sinai has a rank of 20 in research and a 62 in primary care Susan is also a published doctor. She has 29 publication published. The most recent publication is: A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors. She accepts Medicare payments and is registered with Medicare.gov.
![]() |
Dr. David H. Ebb, MD
![]() ![]() |
![]() |
Dr. Nicolas V. Currier, MD
![]() |
![]() |
Dr. Barry H. Paw, MD
![]() ![]() |
![]() |
Dr. Angela M. Feraco, MD
![]() |
![]() |
Dr. Natasha Frederick, MD
![]() |
![]() |
Dr. Elizabeth A. Mullen, MD
![]() |
![]() |
Dr. Andrew L. Kung, MD
![]() ![]() |
![]() |
Dr. Elisha D. Waldman, MD
![]() |